Industry litigation – Page 2
-
BusinessPharmaceuticals roundup 2023
Regulatory and pricing reforms have topped industry agendas in 2023, while weight loss drugs surged and Covid-19 therapies waned
-
OpinionCompounding problems
Regulating the line between a vital service and grey-market profiteering is a mess
-
-
BusinessWeight-loss drug shortages prompt copycats and counterfeits
Novo Nordisk and Eli Lilly have struggled to meet huge demand for new hormone mimic obesity treatments
-
BusinessUK Reach costs set to be slashed under government proposal
Industry may need less hazard data to register chemicals under the regime
-
BusinessThree US juries side with cancer victims over Bayer on Roundup
Bayer unit Monsanto has lost its ‘winning streak’ of nine defence verdicts, and the company plans to appeal
-
BusinessChemours is responsible for PFAS pollution, Dutch court rules
Interim decision holds DuPont spin-off liable for environmental damage caused by historical emissions from Dordrecht plant
-
-
BusinessLapsed US chemical security programme leaves facilities vulnerable
Chemical Facility Anti-Terrorism Standards’ expiry means rules will not be enforced, and companies cannot vet new staff
-
BusinessFines upheld for Advanz Pharma over thyroid drug price increases
UK competition tribunal rules liothyronine pricing ’excessive’ and ‘deliberate’
-
OpinionWho knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
-
BusinessJ&J subsidiary sues more talc researchers
Lawsuit claims another study linking talc use to cancer is fraudulent
-
BusinessEnvironmental groups claim US herbicide reapprovals were illegal
Lawsuit says Environmental Protection Agency ignored serious risks with 2,4-D-containing Enlist products
-
BusinessUK diverges from EU rules with cosmetics animal testing ban
UK will no longer allow Reach-required animal tests intended to prove worker safety
-
BusinessUS supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
BusinessDuPont and a senior employee plead guilty to criminal negligence
$16 million in fines and probation related to fatal methyl mercaptan leak at La Porte, US
-
OpinionWill a court overturn abortion drug’s approval?
Tangle between regulation and politics makes uncomfortable viewing from industry
-
BusinessJ&J proposes to pay nearly $9 billion to settle talc lawsuits
Company re-files for bankruptcy of a subsidiary in the hopes of resolving tens of thousands of claims its products caused cancer
-
BusinessNew Jersey sues Dow Chemical and others over 1,4-dioxane pollution
US State wants companies to be held accountable for cleaning up widespread contamination
-
BusinessFragrance firms face coordinated cartel probe
Givaudan, Firmenich, Symrise and IFF raided by competition authorities